DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.
 
Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Degradation by Dipeptidyl Peptidase IV > Dipeptidyl-Peptidase IV Inhibitors > Journal Article

(Journal Article): The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.
 
Nauck MA, El-Ouaghlidi A (Diabeteszentrum Bad Lauterberg, Kirchberg 21, 37431, Bad Lauterberg im Harz, Germany., M.Nauck@diabeteszentrum.de )
 
IN: Diabetologia 2005; 48(4):608-611
Impact Factor(s) of Diabetologia: 5.583 (2004), 5.689 (2003), 5.136 (2002), 6.299 (2001)

Fulltext:    HTML  PDF

ABSTRACT: n.a.

TYPE OF PUBLICATION: Review

Articles citing this article:



 
Respond on this Journal Article!
Hint: Your Response should directly apply to The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is Dipeptidyl-Peptidase IV Inhibitors.